Unity: Vector's Performance Has Been Good But Not Great (Downgrade)

Unity's stock should benefit from AI ad tech, but modest Q2 results warrant near-term caution. Click here to find out why U ...

Unity Software: Double-Digit Growth Is Possible With Multiple Upside Potential

Unity Software is set for double-digit growth with momentum from its CS and GS segments and the launch of its Vector AI ad ...
Nasdaq

UNITY Biotechnology to Present 36-Week Data from ASPIRE Phase 2B Study at ARVO 2025 Annual Meeting

UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...
VentureBeat

Unity acquires 3D data firm Pixyz Software

Unity said it has acquired Pixyz Software, a provider of 3D data preparation and optimization software. The price wasn’t disclosed. With Pixyz’s portfolio of products, creators in many industries can ...
VentureBeat

Databricks open-sources Unity Catalog, challenging Snowflake on interoperability for data workloads

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Today, Databricks kicked off its annual ...
Nasdaq

UNITY Biotechnology Reports Q1 2025 Financial Results and ASPIRE Study Data on UBX1325 for Diabetic Macular Edema

UNITY Biotechnology, Inc. reported its financial results for the first quarter of 2025, highlighting the 24-week and partial 36-week topline data from its Phase 2b ASPIRE study in diabetic macular ...